HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.

AbstractBACKGROUND:
The nuclear receptors peroxisome proliferator-activated receptor-alpha (PPARalpha) and retinoid X receptor alpha (RXRalpha) stimulate the expression of key enzymes of free fatty acid (FFA) oxidation. We tested the hypothesis that the altered metabolic phenotype of the failing heart involves changes in the protein expression of PPARalpha and RXRalpha.
METHODS AND RESULTS:
Cardiac substrate uptake and oxidation were measured in 8 conscious, chronically instrumented dogs with decompensated pacing-induced heart failure and in 8 normal dogs by infusing 3 isotopically labeled substrates: 3H-oleate, 14C-glucose, and 13C-lactate. Although myocardial O2 consumption was not different between the 2 groups, the rate of oxidation of FFA was lower (2.8+/-0.6 versus 4.7+/-0.3 micromol x min(-1) x 100g(-1)) and of glucose was higher (4.6+/-1.0 versus 1.8+/-0.5 micromol x min(-1) x 100g(-1)) in failing compared with normal hearts (P<0.05). The rates of lactate uptake and lactate output were not significantly different between the 2 groups. In left ventricular tissue from failing hearts, the activity of 2 key enzymes of FFA oxidation was significantly reduced: carnitine palmitoyl transferase-I (0.54+/-0.04 versus 0.66+/-0.04 micromol x min(-1) x g(-1)) and medium chain acyl-coenzyme A dehydrogenase (MCAD; 1.8+/-0.1 versus 2.9+/-0.3 micromol x min(-1) x g(-1)). Consistently, the protein expression of MCAD and of RXRalpha were significantly reduced by 38% in failing hearts, but the expression of PPARalpha was not different. Moreover, there were significant correlations between the expression of RXRalpha and the expression and activity of MCAD.
CONCLUSIONS:
Our results provide the first evidence for a link between the reduced expression of RXRalpha and the switch in metabolic phenotype in severe heart failure.
AuthorsJuan Carlos Osorio, William C Stanley, Axel Linke, Michele Castellari, Quy N Diep, Ashish R Panchal, Thomas H Hintze, Gary D Lopaschuk, Fabio A Recchia
JournalCirculation (Circulation) Vol. 106 Issue 5 Pg. 606-12 (Jul 30 2002) ISSN: 1524-4539 [Electronic] United States
PMID12147544 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carbon Isotopes
  • Carbon Radioisotopes
  • Fatty Acids
  • Protein Isoforms
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Retinoic Acid
  • Retinoid X Receptors
  • Transcription Factors
  • Tritium
  • Oleic Acid
  • Lactic Acid
  • Fatty Acid Desaturases
  • Acyl-CoA Dehydrogenase
  • Carnitine O-Palmitoyltransferase
  • Carboxy-Lyases
  • malonyl-CoA decarboxylase
  • Acetyl-CoA Carboxylase
  • Glucose
Topics
  • Acetyl-CoA Carboxylase (analysis)
  • Acyl-CoA Dehydrogenase
  • Animals
  • Carbon Isotopes
  • Carbon Radioisotopes
  • Carboxy-Lyases (analysis)
  • Cardiac Pacing, Artificial
  • Carnitine O-Palmitoyltransferase (analysis)
  • Disease Models, Animal
  • Dogs
  • Enzyme Activation
  • Fatty Acid Desaturases (analysis)
  • Fatty Acids (metabolism)
  • Glucose (metabolism, pharmacokinetics)
  • Heart Failure (metabolism, pathology)
  • Hemodynamics
  • Lactic Acid (metabolism, pharmacokinetics)
  • Male
  • Mitochondria, Heart (enzymology)
  • Myocardium (chemistry, metabolism, pathology)
  • Oleic Acid (metabolism, pharmacokinetics)
  • Oxidation-Reduction
  • Protein Isoforms (metabolism)
  • Receptors, Cytoplasmic and Nuclear (analysis, metabolism)
  • Receptors, Retinoic Acid (analysis, metabolism)
  • Retinoid X Receptors
  • Transcription Factors (analysis, metabolism)
  • Tritium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: